Treatment of Distal DVT

A, based on consistent, good-quality patient-oriented evidence.) Practice Pointers The term VTE encompasses a spectrum of disease ranging from mild calf symptoms from DVT to life-threatening cardiopulmonary collapse from PE. Six of the trials used vitamin K antagonists as the active treatment agent, and two used the low-molecular-weight heparin nadroparin (not available in the United States). The American College of Chest Physicians endorses a strategy of observation with serial ultrasonography to evaluate for clot progression in select patients with distal DVT and no risk factors.